tegavivint (BC2059)

News alerts, weekly reports and conference planners

Company:

Apollomics, Iterion Therap

Drug class:

β-catenin inhibitor, Wnt signalling pathway inhibitor

Related drugs:

Chr inv(3)t(3;3) + MECOM overexpression	Acute Myelogenous Leukemia	Chr inv(3)t(3;3) + MECOM overexpression	Acute Myelogenous Leukemia	venetoclax + BC2059 Sensitive: D – Preclinical venetoclax + BC2059 Sensitive : D	venetoclax + BC2059 Sensitive: D – Preclinical venetoclax + BC2059 Sensitive : D
Chr inv(3)t(3;3) + MECOM overexpression	Acute Myelogenous Leukemia	Chr inv(3)t(3;3) + MECOM overexpression	Acute Myelogenous Leukemia	OTX015 + BC2059 Sensitive: D – Preclinical OTX015 + BC2059 Sensitive : D	OTX015 + BC2059 Sensitive: D – Preclinical OTX015 + BC2059 Sensitive : D

Associations
(2)